Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.31 |
| ▸ | NOS2 | P35228 | 4/20 | 0.36 |
| ▸ | NOS1 | P29475 | 3/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.35 |
| ▸ | CCR1 | P32246 | 1/20 | 0.33 |
| ▸ | CCR8 | P51685 | 1/20 | 0.33 |
| ▸ | PDE8B | O95263 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | CXCR4 | P61073 | 1/20 | 0.33 |
| ▸ | MBOAT4 | Q96T53 | 1/20 | 0.32 |
| ▸ | MPO | P05164 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | KDM1A | O60341 | 1/20 | 0.31 |
| ▸ | MAOA | P21397 | 1/20 | 0.31 |
| ▸ | MAOB | P27338 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6915777 | 0.97 | NOS2 (0.36) | NOS2NOS1NOS3CCR1CCR8 | |
| Bromide SCHEMBL6917946 | 0.86 | NOS2 (0.34) | NOS2NOS1NOS3CCR1CCR8 | |
| SCHEMBL6917369 | 0.84 | NOS2 (0.35) | NOS2NOS1NOS3CCR1CCR8 | |
| Hydrochloric Acid SCHEMBL6918084 | 0.83 | CXCR4 (0.35) | NOS2NOS1NOS3CCR1CCR8 | |
| SCHEMBL7027270 | 0.83 | NOS2 (0.45) | NOS2NOS1NOS3CCR1CCR8 | |
| SCHEMBL20032025 | 0.78 | NOS3 (0.41) | NOS2NOS3CCR1CCR8PDE8B | |
| SCHEMBL20897039 | 0.74 | TAAR1 (0.47) | NOS2NOS3CCR1CCR8PDE8B | |
| SCHEMBL20279218 | 0.74 | NOS3 (0.37) | NOS2NOS3CCR1CCR8PDE8B | |
| SCHEMBL20099893 | 0.74 | NOS3 (0.37) | NOS2NOS3CCR1CCR8PDE8B | |
| SCHEMBL2614966 | 0.70 | KDM4E (0.46) | NOS2NOS1NOS3CCR1CCR8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040242893-A1 | Catalyst composition | EXXONMOBIL CHEMICAL PATENTS INC. | 2004-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040242893-A1 | Catalyst composition | MLX, BMX, CDYL | OPRM1 339/4885NOS2 1938/4885NOS1 3152/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.